Evidence map›Paper›PMID 35448159›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer.

Tomohito Tanaka, Shoko Ueda, Shunsuke Miyamoto, Sousuke Hashida, Shinichi Terada, Hiromi Konishi, Yuhei Kogata, Kohei Taniguchi, Kazumasa Komura, Masahide Ohmichi

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tomohito TanakaDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.ORCID 0000-0003-4210-701X
Shoko UedaDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Shunsuke MiyamotoDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Sousuke HashidaDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Shinichi TeradaDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Hiromi KonishiDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Yuhei KogataDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Kohei TaniguchiTranslational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Kazumasa KomuraTranslational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Masahide OhmichiDepartment of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Osaka University of Pharmaceutical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minimally invasive surgery (MIS) is performed to treat cervical cancer patients; however, a recent study showed that MIS was associated with higher recurrence and death rate compared with abdominal radical hysterectomy (ARH). In the current study, the prognosis of patients with early-stage cervical cancer who underwent MIS with vaginal closure or ARH was evaluated. One hundred and eighty-two patients underwent radical hysterectomy for cervical cancer with stage of IA2, IB1, and IIA1. MIS was performed by laparoscopy or a robot using the vaginal closure method. Disease-free survival (DFS) and overall survival (OS) were evaluated between the groups. Among the patients, 67 underwent MIS and 115 underwent ARH. The recurrence rate was 4.5% in MIS patients and 3.5% in ARH patients with a median follow-up (interquartile range) of 36 (18-60) and 78 (48-102) months, respectively. DFS and OS were not different between the groups (3y-DFS, 95.3% vs. 96.1%,

Indexed as

Uterine Cervical NeoplasmsFemaleHumansHysterectomyNeoplasm StagingPrognosisRetrospective Studiesminimally invasive surgeryradical hysterectomyuterine cervical cancer

Identifiers

PMID35448159
PMCPMC9026697
OpenAlexW4220926784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.